P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA

Detalles Bibliográficos
Autores principales: LI, Zengping, Wu, Runhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429981/
http://dx.doi.org/10.1097/01.HS9.0000973352.39161.d6
_version_ 1785090847461605376
author LI, Zengping
Wu, Runhui
author_facet LI, Zengping
Wu, Runhui
author_sort LI, Zengping
collection PubMed
description
format Online
Article
Text
id pubmed-10429981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104299812023-08-17 P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA LI, Zengping Wu, Runhui Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429981/ http://dx.doi.org/10.1097/01.HS9.0000973352.39161.d6 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
LI, Zengping
Wu, Runhui
P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA
title P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA
title_full P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA
title_fullStr P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA
title_full_unstemmed P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA
title_short P1619: LOME PILOT STUDY: A MULTICENTER CONTROLLED RANDOMIZED CLINICAL TRIAL OF LOW- VERSUS INTERMEDIATE-DOSE IMMUNE TOLERANCE INDUCTION WITH RECOMBINANT FACTOR VIII (OMFILOCTOCOG ALFA, SCT800) IN CHINA
title_sort p1619: lome pilot study: a multicenter controlled randomized clinical trial of low- versus intermediate-dose immune tolerance induction with recombinant factor viii (omfiloctocog alfa, sct800) in china
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429981/
http://dx.doi.org/10.1097/01.HS9.0000973352.39161.d6
work_keys_str_mv AT lizengping p1619lomepilotstudyamulticentercontrolledrandomizedclinicaltrialoflowversusintermediatedoseimmunetoleranceinductionwithrecombinantfactorviiiomfiloctocogalfasct800inchina
AT wurunhui p1619lomepilotstudyamulticentercontrolledrandomizedclinicaltrialoflowversusintermediatedoseimmunetoleranceinductionwithrecombinantfactorviiiomfiloctocogalfasct800inchina

Ejemplares similares